AAAAAA

   
Results: 1-8 |
Results: 8
THE EFFICACY OF ORAL CYPROTERONE-ACETATE IN COMBINATION WITH ETHINYLESTRADIOL IN ACNE TARDA OF THE FACIAL TYPE
Authors: GOLLNICK H ALBRING M BRILL K
Citation: H. Gollnick et al., THE EFFICACY OF ORAL CYPROTERONE-ACETATE IN COMBINATION WITH ETHINYLESTRADIOL IN ACNE TARDA OF THE FACIAL TYPE, Journal of dermatological treatment, 9(2), 1998, pp. 71-79
GESTODENE AND DESOGESTREL DO NOT HAVE A DIFFERENT INFLUENCE ON CONCENTRATION PROFILES OF ETHINYLESTRADIOL IN WOMEN TAKING ORAL-CONTRACEPTIVES - RESULTS OF ISOTOPE-DILUTION MASS-SPECTROMETRY MEASUREMENTS
Authors: SIEKMANN L SIEKMANN A BIDLINGMAIER F BRILL K ALBRING M
Citation: L. Siekmann et al., GESTODENE AND DESOGESTREL DO NOT HAVE A DIFFERENT INFLUENCE ON CONCENTRATION PROFILES OF ETHINYLESTRADIOL IN WOMEN TAKING ORAL-CONTRACEPTIVES - RESULTS OF ISOTOPE-DILUTION MASS-SPECTROMETRY MEASUREMENTS, European journal of endocrinology, 139(2), 1998, pp. 167-177
FAILURE-TO-THRIVE AND SURVIVAL IN GERIATRIC-PATIENTS
Authors: BRILL K MCMURTRY C GAYLE R PARHAM I OSGOOD N
Citation: K. Brill et al., FAILURE-TO-THRIVE AND SURVIVAL IN GERIATRIC-PATIENTS, Journal of the American Geriatrics Society, 46(9), 1998, pp. 33-33
A MULTICENTER, UNCONTROLLED CLINICAL INVESTIGATION OF THE CONTRACEPTIVE EFFICACY, CYCLE CONTROL, AND SAFETY OF A NEW LOW-DOSE ORAL-CONTRACEPTIVE CONTAINING 20 MU-G ETHINYL ESTRADIOL AND 100 MU-G LEVONORGESTRELOVER 6 TREATMENT CYCLES
Authors: BANNEMERSCHULT R HANKER JP WUNSCH C FOX P ALBRING M BRILL K
Citation: R. Bannemerschult et al., A MULTICENTER, UNCONTROLLED CLINICAL INVESTIGATION OF THE CONTRACEPTIVE EFFICACY, CYCLE CONTROL, AND SAFETY OF A NEW LOW-DOSE ORAL-CONTRACEPTIVE CONTAINING 20 MU-G ETHINYL ESTRADIOL AND 100 MU-G LEVONORGESTRELOVER 6 TREATMENT CYCLES, Contraception, 56(5), 1997, pp. 285-290
INVESTIGATION OF THE INFLUENCE OF 2 LOW-DOSE MONOPHASIC ORAL-CONTRACEPTIVES CONTAINING 20 MU-G ETHINYLESTRADIOL 75 MU-G GESTODENE AND 30 MU-G ETHINYLESTRADIOL 75 MU-G GESTODENE, ON LIPID-METABOLISM IN AN OPEN RANDOMIZED TRIAL
Authors: BRILL K THEN A BEISIEGEL U JENE A WUNSCH C LEIDENBERGER F
Citation: K. Brill et al., INVESTIGATION OF THE INFLUENCE OF 2 LOW-DOSE MONOPHASIC ORAL-CONTRACEPTIVES CONTAINING 20 MU-G ETHINYLESTRADIOL 75 MU-G GESTODENE AND 30 MU-G ETHINYLESTRADIOL 75 MU-G GESTODENE, ON LIPID-METABOLISM IN AN OPEN RANDOMIZED TRIAL, Contraception, 54(5), 1996, pp. 291-297
INHIBITION OF OVULATION BY AN ORAL-CONTRACEPTIVE CONTAINING 100 MU-G LEVONORGESTREL IN COMBINATION WITH 20 MU-G ETHINYLESTRADIOL
Authors: SPONA J FEICHTINGER W KINDERMANN C WUNSCH C BRILL K
Citation: J. Spona et al., INHIBITION OF OVULATION BY AN ORAL-CONTRACEPTIVE CONTAINING 100 MU-G LEVONORGESTREL IN COMBINATION WITH 20 MU-G ETHINYLESTRADIOL, Contraception, 54(5), 1996, pp. 299-304
THE INFLUENCE OF THE DOSE OF ETHINYLESTRADIOL IN ORAL-CONTRACEPTIVES ON FOLLICLE GROWTH
Authors: TEICHMANN AT BRILL K ALBRING M SCHNITKER J WOJTYNEK P KUSTRA E
Citation: At. Teichmann et al., THE INFLUENCE OF THE DOSE OF ETHINYLESTRADIOL IN ORAL-CONTRACEPTIVES ON FOLLICLE GROWTH, Gynecological endocrinology, 9(4), 1995, pp. 299-305
CLINICAL-EXPERIENCE WITH A MODERN LOW-DOSE GESTODENE-CONTAINING ORAL-CONTRACEPTIVE IN ADOLESCENTS
Authors: BRILL K SCHNITKER J ALBRING M
Citation: K. Brill et al., CLINICAL-EXPERIENCE WITH A MODERN LOW-DOSE GESTODENE-CONTAINING ORAL-CONTRACEPTIVE IN ADOLESCENTS, Advances in contraception, 10(4), 1994, pp. 237-247
Risultati: 1-8 |